MedPath

TWi Pharmaceuticals, Inc.

TWi Pharmaceuticals, Inc. logo
🇹🇼Taiwan
Ownership
Subsidiary
Established
2010-01-01
Employees
344
Market Cap
-
Website
http://www.twipharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

34

FDA:34

Drug Approvals

Fluoxetine HCl

Approval Date
Dec 29, 2023
FDA

Forfivo

Approval Date
Dec 27, 2023
FDA

bupropion hydrochloride

Approval Date
Dec 27, 2023
FDA

Topiramate

Approval Date
Dec 5, 2023
FDA

Diltiazem Hydrochloride

Approval Date
Nov 8, 2023
FDA

testosterone

Approval Date
Nov 8, 2023
FDA

Potassium Chloride

Approval Date
Nov 8, 2023
FDA

Dicyclomine Hydrochloride

Approval Date
Nov 8, 2023
FDA

Testosterone

Approval Date
Nov 7, 2023
FDA

Diltiazem Hydrochloride

Approval Date
Nov 7, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath